Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/9/2018
SIETES contiene 92565 citas

 
 
 1 a 20 de 551 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Sinha MS, Curfman GD, Carrier MA. Antitrust, market exclusivity, and transparency in the pharmaceutical industry. JAMA 2018;319:12 de junio. [Ref.ID 102779]
2.Enlace a cita original Cita con resumen
McCall C. Biosimilars for insulin: a cost-saving alternative?. Lancet 2018;392:11 de agosto. [Ref.ID 102770]
5. Cita con resumen
nónimo. FDA Withdraws guidance relating to biosimilar development. DIA Daily 2018:8. [Ref.ID 102702]
6. Cita con resumen
Anónimo. Increasing cost of insulin sparks concern. DIA Daily 2018:1. [Ref.ID 102700]
7. Cita con resumen
Feuerstein A. After watching Trump’s drug speech, investors poured big money into biotech funds. STAT Daily Recap 2018:4. [Ref.ID 102605]
9. Cita con resumen
Silverman E. STAT Plus: Spending growth on prescription drugs will double this year. STAT Daily Recap 2018:3. [Ref.ID 102457]
11. Cita con resumen
13.Enlace a cita original Cita con resumen
Mershon E. STAT Plus: Drug makers dodged $1.3 billion in payments to Medicaid, report finds. STAT Daily Recap 2017:20 de diciembre. [Ref.ID 102173]
14. Cita con resumen
Anónimo. Pfizer to sell generic version of sildenafil. DIA Daily 2017:14. [Ref.ID 102163]
15. Cita con resumen
Anónimo. Dutch health minister considers compulsory license over drug prices. DIA Daily 2017:1. [Ref.ID 102148]
16.Enlace a cita original Cita con resumen
Prasad V, Mailan S. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern Med 2017;177:1569-75. [Ref.ID 102051]
17. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
18. Cita con resumen
Fralick M, Avorn J, Kesselheim AS. The price of crossing the border for medications. N Engl J Med 2017;377:311-3. [Ref.ID 101925]
19. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
20. Cita con resumen
Anónimo. Pfizer increases US list prices of 91 drugs by average of 20 percent. DIA Daily 2017:1. [Ref.ID 101624]
Seleccionar todas
 
 1 a 20 de 551 siguiente >>